Zikani Therapeutics Overview
- Founded
- 2015

- Status
- Acquired/Merged
- Employees
- 17

- Latest Deal Type
- M&A
- Latest Deal Amount
- $25.6M

Zikani Therapeutics General Information
Description
Developer of novel antibiotic compounds designed to improve the lives of patients suffering from serious infections. The company's antibiotic compounds harness the power of synthetic chemistry and microbiology used in the treatment of serious, multi-drug resistant gram-negative infections, enabling patients to recover quickly from multiple infection conditions.
Contact Information
(Operating Subsidiary)
- 480 Arsenal Way
- Suite 130
- Watertown, MA 02472
- United States
Zikani Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Merger/Acquisition | 01-Apr-2021 | $25.6M | 000.00 | 000.00 | Completed | Generating Revenue |
5. Later Stage VC (Series A1) | 09-Apr-2020 | 00.00 | 000.00 | 000.00 | Completed | Clinical Trials - General |
4. Later Stage VC (Series A) | 02-Apr-2018 | 0000 | 000.00 | 000.00 | Completed | Startup |
3. Grant | 26-Mar-2018 | 00.00 | 000.00 | Completed | Startup | |
2. Later Stage VC (Series A) | 25-Feb-2015 | $22.3M | $22.3M | 000.00 | Completed | Startup |
1. Accelerator/Incubator | Completed | Startup |
Zikani Therapeutics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A1 | 000,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Series A | 00,000,000 | 00.000000 | 00.00 | 00 | 00 | 00 | 00 | 00.00 |
Zikani Therapeutics Comparisons
Industry
00000000
00000 00
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialZikani Therapeutics Competitors (51)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Visterra | Formerly VC-backed | Waltham, MA | 00 | 00000 | 000000&0 | 00000 |
00000 000000000000 | Venture Capital-Backed | San Diego, CA | 0 | 000.00 | 0000000000 | 000.00 |
0000000 0000000000 | Venture Capital-Backed | Niel, Belgium | 00 | 000.00 | 00000000000 | 000.00 |
00000000 000000000 | Formerly VC-backed | San Diego, CA | 000 | 00000 | 000000000 - | 00000 |
000000 000000 | Venture Capital-Backed | Boston, MA | 00 | 00000 | 00000000 | 00000 |
Zikani Therapeutics Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialZikani Therapeutics Former Investors (7)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Advent Life Sciences | Venture Capital | Minority | 000 0000 | 000000 0 | |
Blavatnik Biomedical | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | |
CARB-X | University | 000 0000 | 000000 0 | ||
Gurnet Point Capital | PE/Buyout | Minority | 000 0000 | 000000 0 | |
Novartis Venture Fund | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |